Bio-Rad Laboratories (NYSE:BIO.B) Hits New 1-Year High at $464.10
Bio-Rad Laboratories (NYSE:BIO.B) Hits New 1-Year High at $464.10
Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Rating)'s share price hit a new 52-week high during trading on Wednesday . The company traded as high as $464.10 and last traded at $464.10, with a volume of 0 shares. The stock had previously closed at $464.10.
生物拉德實驗室公司（紐約證券交易所代碼：BIO.B — 獲取評級）的股價在周三交易期間創下 52 周新高。該公司的交易價格高達 464.10 美元，最後交易價為 464.10 美元，交易量為 0 股。該股票之前收盤價為 464.10 美元。
Analysts Set New Price Targets
分析師設定新的價格目標
Separately, TheStreet upgraded Bio-Rad Laboratories from a "d+" rating to a "c-" rating in a report on Monday.
另外，街升級 Bio-Rad 實驗室從「d +」評級為「c-」在週一報告中的評級。
Bio-Rad Laboratories Price Performance
生物拉德實驗室價格性能
The company has a quick ratio of 4.29, a current ratio of 5.55 and a debt-to-equity ratio of 0.12. The stock has a fifty day moving average price of $415.36 and a 200 day moving average price of $411.90.
該公司的快速比率為 4.29，流動比率為 5.55，債務與權益比率為 0.12。該股票的五十天移動平均價為 415.36 美元，以及 200 日移動平均價格為 411.90 美元。
Bio-Rad Laboratories (NYSE:BIO.B – Get Rating) last announced its earnings results on Thursday, February 16th. The company reported $3.31 EPS for the quarter. The firm had revenue of $730.29 million during the quarter. Bio-Rad Laboratories had a positive return on equity of 4.59% and a negative net margin of 129.66%.
生物拉德實驗室（紐約證券交易所代碼：BIO.B-獲取評級）上週四宣布了其收益業績，週四，2 月 16 日。該公司報告了本季度每股 3.31 美元的每股盈利。該公司在本季度的收入為 730.29 億美元。生物拉德實驗室的股權回報率為 4.59％，負淨利潤率為 129.66％。
Bio-Rad Laboratories Company Profile
生物拉德實驗室公司簡介
(Get Rating)
(取得評分)
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Bio-Rad 實驗室公司在美國、歐洲、亞洲、加拿大和拉丁美洲生產並經銷生命科學研究和臨床診斷產品。該公司通過生命科學和臨床診斷部門開展業務。生命科學部門開發、製造和銷售一系列用於研究技術、生物製藥生產過程和食品測試制度的試劑、儀器和實驗室儀器。
Read More
閱讀更多
- Get a free copy of the StockNews.com research report on Bio-Rad Laboratories (BIO.B)
- Put High-Yield Paychex, Inc. On Your Watchlist
- The Squeeze Is On For EVGo, Rally To Follow
- Is The Bottom In For RH, Or Is This Just A Stopping Point?
- Dividend King H.B. Fuller Signals Slowing In 2023
- Is SoFi Technologies a Buy in the Midst of a Banking Crisis?
- 獲取有關生物拉德實驗室（BIO.B）的研究報告的免費副本
- 將高收益 Paychex 公司放在您的監視列表中
- eVGo 的擠壓正在進行，集會跟隨
- 是 RH 的底部，還是這只是一個停止點？
- 股息國王 H.B 富勒信號在 2023 年放緩
- SoFi 技術在銀行危機中是否可以購買？
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
每日接收 Bio-Rad 實驗室的新聞和評分 -在下面輸入您的電子郵件地址，以通過 MarketBeat.com 的免費每日電子郵件通訊接收 Bio-Rad 實驗室及相關公司的最新新聞和分析師評級的簡要每日摘要。
譯文內容由第三人軟體翻譯。